Post-licensure comparative study of unusual high-pitched crying and prolonged crying following COMVAX™ and placebo versus PedvaxHIB™ and RECOMBIVAX HB™ in healthy infants

Vaccine

Volumn 21, Issue 3-4, 2002, Pages 181-187

  Kaplan, Karen M ^a   Rusche, Steven A ^a   Lakkis, Hassan D ^a   Bottenfield, Gerald ^b   Guerra, Fernando A ^c   Guerrero, Juan ^d   Keyserling, Harry ^e   Felicione, Elise ^a   Hesley, Teresa M ^a   Boslego, John W ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

^b R/D Clinical Research   (United States)

^c San Antonio Metropolitan Health District   (United States)

^d RADIANT RESEARCH   (United States)

^e EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Prolonged crying; Unusual high pitched crying; Vaccine safety

Indexed keywords

HAEMOPHILUS INFLUENZAE TYPE B HEPATITIS B VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; RECOMBINANT HEPATITIS B VACCINE; BACTERIAL POLYSACCHARIDE; HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE NEISSERIA MENINGITIDIS OUTER MEMBRANE PROTEIN CONJUGATE VACCINE; HAEMOPHILUS INFLUENZAE-TYPE B POLYSACCHARIDE-NEISSERIA MENINGITIDIS OUTER MEMBRANE PROTEIN CONJUGATE VACCINE; HAEMOPHILUS VACCINE; HEPATITIS B VACCINE; OUTER MEMBRANE PROTEIN; RECOMBINANT VACCINE; VACCINE;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRYING; DOUBLE BLIND PROCEDURE; DRUG SAFETY; FEMALE; FOLLOW UP; HUMAN; HUMAN EXPERIMENT; INFANT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SEIZURE; STATISTICAL SIGNIFICANCE; VACCINATION; IMMUNIZATION; PSYCHOLOGICAL ASPECT; SAFETY;

BACTERIAL OUTER MEMBRANE PROTEINS; CRYING; DOUBLE-BLIND METHOD; HAEMOPHILUS VACCINES; HEPATITIS B VACCINES; HUMANS; IMMUNIZATION SCHEDULE; INFANT; POLYSACCHARIDES, BACTERIAL; SAFETY; VACCINATION; VACCINES, COMBINED; VACCINES, SYNTHETIC;

EID: 0037073578     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(02)00469-3     Document Type: Article

References (25)

1. West D.J., Hesley T.M., Jonas L.C.et al. Safety and immunogenicity of a bivalent Haemophilus influenzae type b/hepatitis B vaccine in healthy infants. Pediatr. Infect. Dis. J. 16:1997;593-599.
2. Centers for Disease Control and Prevention. Combination vaccines for childhood immunization. MMWR 1999;48:1-15.
3. Barnard G.A. A new test for 2 × 2 tables. Nature. 156(3954):1945;177.
4. Barnard G.A. Significance tests for 2 × 2 tables. Biometrika. 24:1947;123-138.
5. SAS Statistical Package. Cary, NC: SAS Institute, 1996.
6. Miettinen O., Nurminen M. Comparative analysis of two rates. Stat. Med. 4:1985;213-226.
7. Farrington C.P., Manning G. Test statistics and sample size formulae for comparative binomial trials with null hypothesis of non-zero risk difference or non-unity relative risk. Stat. Med. 9:1990;1447-1454.
8. Cherry JD, Shields WD. Encephalitis and meningoencephalitis. In: Feigin RD, Cherry JD, editors. Textbook of Pediatric Infectious Diseases. 4th Ed. Philadelphia, PA: WB Saunders, 1998, p. 457-68.
9. Strõm J. Is universal vaccination against pertussis always justified? Br. Med. J. 2:1960;1184-1185.
10. Strõm J. Further experience of reactions, especially of a cerebral nature, in conjunction with triple vaccination: a study based on vaccinations in Sweden 1959-1965. Br. Med. J. 4:1967;320-323.
11. Stewart G.T. Vaccination against whooping cough: efficacy versus risks. Lancet. 29:1977;234-237.
12. Gangarosa E.J., Galazka A.M., Wolfe C.R.et al. Impact of anti-vaccine movements on pertussis control: the untold story. Lancet. 351:1998;356-361.
13. Manclark CR, Hill JC, editors. Proceedings of the International Symposium on Pertussis 1978, Nov 1-3. Discussion of Part 5. Bethesda, MD: Department of Health, Education, and Welfare, National Institutes of Health, 1978. p. 304-15.
14. Committee on Infectious Diseases (the Red Book Committee). The relationship between pertussis vaccine and central nervous system sequelae: Continuing assessment. Pediatrics 1996;97:279-81.
15. Centers for Disease Control and Prevention. Update: vaccine side effects, adverse reactions, contraindications, and precautions after DTP vaccination recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1996;45(RR-12):22-35.
16. Partanen T.J., Wasz-Höckert O., Vuorenkoski V., Theorell K., Valanne E.H., Lind J. Auditory identification of pain cry signals of young infants in pathological conditions and its sound spectrographic basis. Ann. Paediat. Fenn. 13:1967;56-63.
17. American Academy of Pediatrics. Pertussis. In: Pickering LK, editor. 2000 Red Book: Report of the Committee on Infectious Diseases. 25th Ed. Elk Grove Village, IL: American Academy of Pediatrics, 2000. p. 444.
18. Cody C.L., Baraff L.J., Cherry J.D.et al. Nature and rates of adverse reactions associated with DTP and DT immunizations in infants and children. Pediatrics. 68:1981;650-660.
19. Braun M.M., Mootrey G.T., Salive M.E.et al. Infant immunization with acellular pertussis vaccines in the United States: assessment of the first 2 years data from the vaccine adverse event reporting system (VAERS). Pediatrics. 106:2000;e51.
20. Morselli P.L., Garattini S. Monosodium glutamate and the Chinese restaurant syndrome. Nature. 227:1970;611-612.
21. Dhume V.G., Agshikar N.V., Diniz R.S. Placebo-induced side effects in healthy volunteers. Clinician. 39:1975;289-290.
22. Tangrea J.A., Adrianza M.D., Helzer W.E. Risk factors for the development of placebo adverse reactions in a multicenter clinical trial. Ann. Epidemiol. 4:1994;327-331.
23. Drici M.D., Faybaud F., DeLunardo C.et al. Influence of the behavior pattern on the nocebo response of healthy volunteers. Br. J. Clin. Pharmacol. 39:1995;204-206.
24. Gellin B.G., Maibach E.W., Marcuse E.K. Do parents understand immunizations? A national telephone survey. Pediatrics. 106:2000;1097-1102.
25. Offit P.A., Quarles J., Gerber M.A.et al. Addressing parents' concerns: do multiple vaccines overwhelm or weaken the infant's immune system? Pediatrics. 109:2002;124-129.